Mark Brosius Sells 215 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 215 shares of the business's stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90. Following the completion of the sale, the senior vice president now owns 1,768 shares in the company, valued at approximately $970,738.08. The trade was a 10.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Mark Brosius also recently made the following trade(s):

• On Wednesday, June 4th, Mark Brosius sold 215 shares of Intuitive Surgical stock. The stock was sold at an average price of $552.07, for a total transaction of $118,695.05.
• On Friday, May 16th, Mark Brosius sold 20 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.81, for a total transaction of $11,276.20.
• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.00, for a total transaction of $12,386.00.
• On Monday, May 12th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $551.97, for a total transaction of $12,143.34.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total value of $260,725.02.

Intuitive Surgical Trading Up 1.1%

Shares of ISRG traded up $6.10 during mid-day trading on Wednesday, hitting $557.95. The company's stock had a trading volume of 1,146,710 shares, compared to its average volume of 1,648,262. The company's 50-day moving average is $518.20 and its 200-day moving average is $538.82. Intuitive Surgical, Inc. has a 52-week low of $405.08 and a 52-week high of $616.00. The firm has a market capitalization of $199.98 billion, a price-to-earnings ratio of 87.04, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the prior year, the company earned $1.50 EPS. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently modified their holdings of ISRG. Norges Bank purchased a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $2,401,493,000. Nuveen LLC purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. GAMMA Investing LLC lifted its position in Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC lifted its position in Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock valued at $495,845,000 after acquiring an additional 948,902 shares during the last quarter. Finally, Capital Research Global Investors lifted its position in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of analyst reports. Piper Sandler cut their price objective on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Truist Financial reduced their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Evercore ISI cut their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research note on Wednesday, April 23rd. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Finally, Citigroup restated a "buy" rating and set a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Five analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus target price of $596.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.